Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 556 AL 570

Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer's Disease

Morrison C, Rabipour S, Knoefel F, Sheppard C, Taler V.

Curr Alzheimer Res. 2018;15(8):702-715. doi: 10.2174/1567205015666180123123209.

Evidence-Based Nonpharmacological Practices to Address Behavioral and Psychological Symptoms of Dementia

Scales K, Zimmerman S, Miller SJ.

Gerontologist. 2018 Jan 18;58(suppl_1):S88-S102. doi: 10.1093/geront/gnx167.

The neuronal Shc adaptor in Alzheimer's Disease

Triaca V, Coccurello R, Giacovazzo G.

Aging (Albany NY). 2018 Jan 22;10(1):5-6. doi: 10.18632/aging.101368.

High blood pressure, Alzheimer disease and antihypertensive treatment

Marfany A, Sierra C, Camafort M, Doménech M, Coca A.

Panminerva Med. 2018 Mar;60(1):8-16. doi: 10.23736/S0031-0808.18.03360-8. Epub 2018 Jan 25.

Centre- versus home-based exercise among people with mci and mild dementia: study protocol for a randomized parallel-group trial

Middleton LE, Black SE, Herrmann N, Oh PI, Regan K, Lanctot KL.

BMC Geriatr. 2018 Jan 25;18(1):27. doi: 10.1186/s12877-017-0684-0.

A novel language-neutral Visual Cognitive Assessment Test (VCAT): validation in four Southeast Asian countries

Lim L, Ng TP, Ong AP, Tan MP, Cenina AR, Gao Q, Ng A, Kandiah N.

Alzheimers Res Ther. 2018 Jan 22;10(1):6. doi: 10.1186/s13195-017-0333-z.

Predictors of one-year mortality after hospitalization for an exacerbation of COPD

Esteban C, Castro-Acosta A, Alvarez-Martínez CJ, Capelastegui A, López-Campos JL, Pozo-Rodriguez F.

BMC Pulm Med. 2018 Jan 25;18(1):18. doi: 10.1186/s12890-018-0574-z.

Is It Time to Consider Obstructive Sleep Apnea Syndrome a Risk Factor for Alzheimer's Disease?

Liguori C, Placidi F.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):855-856. doi: 10.1164/rccm.201710-2105ED.

Is the Use of Proton-pump Inhibitors a Risk Factor for Alzheimer's Disease? Molecular Mechanisms and Clinical Implications

Ide K, Matsuoka N, Kawakami K.

Curr Med Chem. 2018;25(18):2166-2174. doi: 10.2174/0929867325666180129101049.

Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese

Feng X, Zhou A, Liu Z, Li F, Wei C, Zhang G, Jia J.

J Alzheimers Dis. 2018;61(4):1611-1618. doi: 10.3233/JAD-170530.

Left Ventricular Hypertrophy and Remodeling and Risk of Cognitive Impairment and Dementia: MESA (Multi-Ethnic Study of Atherosclerosis)

Moazzami K, Ostovaneh MR, Ambale Venkatesh B, Habibi M, Yoneyama K, Wu C, Liu K, Pimenta I, Fitzpatrick A, Shea S, McClelland RL, Heckbert S, Gottesman RF, Bluemke DA, Hughes TM, Lima JAC.

Hypertension. 2018 Mar;71(3):429-436. doi: 10.1161/HYPERTENSIONAHA.117.10289. Epub 2018 Jan 29.

Utility of the Spanish version of the Everyday Cognition scale in the diagnosis of mild cognitive impairment and mild dementia in an older cohort from the Argentina-ADNI

Russo MJ, Cohen G, Chrem Mendez P, Campos J, Martín ME, Clarens MF, Tapajoz F, Harris P, Sevlever G, Allegri RF.

Aging Clin Exp Res. 2018 Oct;30(10):1167-1176. doi: 10.1007/s40520-018-0899-8. Epub 2018 Jan 29.

Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia

Park SJ, Lee JE, Lee KS, Kim JS.

Neurol Sci. 2018 Mar;39(3):557-564. doi: 10.1007/s10072-018-3261-1. Epub 2018 Jan 30.

(18)F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia

Higashi T, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.

Ann Nucl Med. 2018 Apr;32(3):206-216. doi: 10.1007/s12149-018-1236-1. Epub 2018 Jan 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias